SEC Form 4 · accession 0000914190-15-000417
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Rosenberg
Director
Period of report
Sep 9, 2015
Accepted (ET)
Sep 11, 2015 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 9, 2015 | A | 58,240 | $0.00 | A | 847,935 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $0.79 | holding | — | — | — | — | May 16, 2024 | Common Stock | 48,864 | 48,864 | D |
| Warrants (right to buy) | $0.85 | holding | — | — | — | May 12, 2015 | May 18, 2020 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1On September 9, 2015, the Company granted 58,240 shares of restricted stock of the Company (the "Restricted Stock") in respect of the service by Mr. Rosenberg as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests 6 months following the grant date.
- F2On May 16, 2014, the Company granted Mr. Rosenberg an option to purchase 48,864 shares of common stock of the Company (the "Option") under the Company's 2004 Stock Incentive Plan. The Option vested immediately upon the grant date with respect to one-third of the shares. The remainder of the Option vests in equal annual installments on each of the first and second anniversaries of the grant date.